ImmuCell Co. (NASDAQ:ICCC)’s share price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $6.48 and traded as low as $6.44. ImmuCell shares last traded at $6.44, with a volume of 344 shares.
The company has a debt-to-equity ratio of 0.27, a quick ratio of 6.25 and a current ratio of 7.26. The business has a 50 day simple moving average of $6.49.
ImmuCell (NASDAQ:ICCC) last released its quarterly earnings results on Monday, May 13th. The biotechnology company reported $0.03 earnings per share (EPS) for the quarter. ImmuCell had a negative net margin of 15.62% and a negative return on equity of 5.71%. The firm had revenue of $4.41 million for the quarter.
About ImmuCell (NASDAQ:ICCC)
ImmuCell Corporation, an animal health company, develops, acquires, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product for calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E.
Featured Story: Equal Weight Rating
Receive News & Ratings for ImmuCell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuCell and related companies with MarketBeat.com's FREE daily email newsletter.